Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 1/00: Drugs for disorders of the alimentary tract or the digestive system
A61P 1/00
Sub-Class
Stats
- 769 US PATENTS IN FORCE
- 382 US APPLICATIONS PENDING
- 183 Total Patent Owners
- 13,510 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12263192 | Compositions for management of disorders of the gastrointestinal tract | Feb 26, 20 | Apr 01, 25 | PanTheryx, Inc. |
| 12264156 | Compounds and pharmaceutical compositions thereof for the treatment of diseases | May 29, 19 | Apr 01, 25 | Galapagos NV |
| 12257251 | Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation | Jul 11, 23 | Mar 25, 25 | INXMED (NANJING) CO., LTD. |
| 12257259 | Nutritional composition comprising 2′-Fucosyllactose (2′ FL) to improve the gastrointestinal barrier | Dec 11, 19 | Mar 25, 25 | Societe des Produits Nestle SA |
| 12257275 | Probiotics and fermentation metabolites for the prevention and treatment of disease conditions in animals | Aug 25, 20 | Mar 25, 25 | PURE CULTURES, INC. |
| 12258423 | Stapled and stitched polypeptides and uses thereof | Nov 17, 20 | Mar 25, 25 | Harvard University President and Fellows of Harvard College |
| 12250956 | Compositions for gut health | Feb 03, 21 | Mar 18, 25 | International N&H Denmark APS |
| 12251391 | Methods of supporting gastrointestinal homeostasis | Nov 08, 19 | Mar 18, 25 | DSM IP Assets B. V. |
| 12251413 | in preparation of drug for treating inflammatory disease or tumor | Sep 05, 22 | Mar 18, 25 | HARBIN KANGLONG PHARMACEUTICAL CO., LTD; YICHUN BINGCHEN AGRICULTURAL TECHNOLOGY DEVELOPMENT CO., LTD.; |
| 12245994 | Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation | Dec 02, 22 | Mar 11, 25 | Elevaid Therapeutics, Inc. |
| 12246064 | Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate | Jan 19, 21 | Mar 11, 25 | Takeda Pharmaceutical Company Limited |
| 12239616 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | Feb 27, 23 | Mar 04, 25 | ABERGAVENNY NV |
| 12239619 | Feb 28, 20 | Mar 04, 25 | Morinaga Milk Industry Co. Ltd.; National University Corporation Kobe University; The Kitasato Institute; | |
| 12239674 | LRH05 isolate, and composition including the same and use thereof | Jun 17, 21 | Mar 04, 25 | SYNBIO TECH INC. |
| 12226433 | Treatment of irritable bowel syndrome with molybdenum | Jul 22, 19 | Feb 18, 25 | The Johns Hopkins University |
| 12226441 | Composition for inhibiting intestinal permeability, treating leaky gut related diseases and/or preventing leaky gut related diseases | Jun 01, 23 | Feb 18, 25 | (6) INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
| 12227565 | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine | Jun 19, 19 | Feb 18, 25 | BIORA THERAPEUTICS, INC. |
| 12220434 | Altering the intestinal microbiome in cystic fibrosis | May 19, 22 | Feb 11, 25 | Trustees of Dartmouth College; Dartmouth-Hitchcock Clinic; |
| 12220445 | Inert matrices for qualitative and semi-quantitative seed amplification assays | Sep 09, 22 | Feb 11, 25 | Amprion, Inc. |
| 12220450 | Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer | Aug 09, 21 | Feb 11, 25 | AMAL THERAPEUTICS SA |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0114,409 | METHODS OF PREPARING A POSTBIOTIC COMPOSITION | Oct 08, 24 | Apr 10, 25 | Not available |
| 2025/0114,413 | SYNBIOTIC SUPPLEMENT FORMULATION | Oct 09, 23 | Apr 10, 25 | Not available |
| 2025/0108,081 | Improved Probiotic Potency of the Yeast Saccharomyces Boulardii | Jan 26, 23 | Apr 03, 25 | Not available |
| 2025/0108,085 | COMPOSITIONS COMPRISING HEMP EXTRACT AND RELATED TEATMENT METHODS | Sep 10, 24 | Apr 03, 25 | Not available |
| 2025/0099,412 | METHOD OF INHIBITING DEGRADING PROTEASE ACTIVITY IN AGING | Jan 18, 23 | Mar 27, 25 | Not available |
| 2025/0099,454 | COMBINATION OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE AND ITS DERIVATIVES WITH A JAK INHIBITOR | Jan 20, 23 | Mar 27, 25 | ABIVAX |
| 2025/0101,070 | Actinohivin Variant Polypeptides and Methods of Treatment Using Them | Oct 08, 24 | Mar 27, 25 | Not available |
| 2025/0090,501 | METHODS OF TREATING GUT MOTILITY DISORDERS | Jan 03, 23 | Mar 20, 25 | The Regents of the University of California |
| 2025/0090,563 | COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE COMPRISING GALACTO-OLIGOSACCHARIDE | Jan 21, 22 | Mar 20, 25 | Not available |
| 2025/0090,600 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITION AND METHODS OF MANUFACTURE | Aug 02, 24 | Mar 20, 25 | Ferring Microbiome Inc. |
| 2025/0090,604 | STRAIN OF PEDIOCOCCUS ACIDILACTICI WITH FUNCTION OF TREATING ULCERATIVE COLITIS AND APPLICATION THEREOF | Dec 01, 24 | Mar 20, 25 | Not available |
| 2025/0090,632 | Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody | Oct 07, 24 | Mar 20, 25 | Not available |
| 2025/0081,970 | POLYMER NANOCOMPOSITES WITH SUB 5NM NANOPARTICLES FOR IMPROVED ANTIMICROBIAL EFFECTIVENESS | May 23, 22 | Mar 13, 25 | SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI |
| 2025/0082,695 | USE OF GLYCEROL FOR INCREASING BUTYRATE PRODUCTION BY BACTERIA IN A CONSORTIUM | Oct 14, 20 | Mar 13, 25 | Not available |
| 2025/0082,582 | POLYMER-ENCAPSULATED DRUG PARTICLES | Nov 21, 24 | Mar 13, 25 | Not available |
| 2025/0082,732 | ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS FOR TREATING ENTERIC DISEASES IN ANIMALS | Aug 02, 24 | Mar 13, 25 | Vets Plus, Inc. |
| 2025/0084,174 | THERAPEUTIC BINDING MOLECULES | Jul 29, 24 | Mar 13, 25 | Not available |
| 2025/0074,991 | METHODS OF TREATING NAUSEA AND VOMITING DISORDERS USING ANTI-GFRAL ANTIBODIES | Jul 30, 24 | Mar 06, 25 | Not available |
| 2025/0073,223 | TARGETED NANOCARRIERS FOR SYSTEMIC DELIVERY OF IRAK4 INHIBITORS TO INFLAMED TISSUES | Sep 03, 24 | Mar 06, 25 | Oregon State University; Oregon Health & Science University; |
| 2025/0073,253 | METHODS OF SUPPORTING GASTROINTESTINAL HOMEOSTASIS | Nov 15, 24 | Mar 06, 25 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 30 Months (last 2 years Issuances)
- 30 Months (last 5 years Issuances)